iRhythm Holdings, Inc. Deferred Tax Assets, Gross
iRhythm Holdings, Inc. (IRTC) had Deferred Tax Assets, Gross of $276.64 million as of 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGross · last filed 2026-02-19
- 2025-12-31: Deferred Tax Assets, Gross $276.64M.
- 2024-12-31: Deferred Tax Assets, Gross $255.02M.
- 2023-12-31: Deferred Tax Assets, Gross $229.84M.
- 2022-12-31: Deferred Tax Assets, Gross $212.26M.
| Period end | Deferred Tax Assets, Gross | Deferred Tax Assets, Gross as first filed |
|---|---|---|
| 2025-12-31 | $276.64M 10-K · filed 2026-02-19 | |
| 2024-12-31 | $255.02M 10-K · filed 2026-02-19 | |
| 2023-12-31 | $229.84M 10-K · filed 2025-02-20 | |
| 2022-12-31 | $212.26M 10-K · filed 2024-02-22 | |
| 2021-12-31 | $178.70M 10-K · filed 2023-02-23 | |
| 2020-12-31 | $144.59M 10-K · filed 2022-02-28 | |
| 2019-12-31 | $111.49M 10-K · filed 2021-02-26 | |
| 2018-12-31 | $66.86M 10-K · filed 2020-03-02 | $65.93M 10-K · filed 2019-03-04 |
| 2017-12-31 | $44.25M 10-K · filed 2019-03-04 | |
| 2016-12-31 | $44.86M 10-K · filed 2018-03-01 | |
| 2015-12-31 | $38.56M 10-K · filed 2017-03-31 | |
| 2014-12-31 | $29.87M 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |